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1. Introduction
   Anxiety disorders are common mental disorders that 
share extreme or pathological anxiety as the primary 
disturbance in mood or emotional tone[1]. Common 
denomination of all anxiety disorders is a state of increased 
fear and exaggerated version of the acute stress response[2]. 
Literature revealed a link between anxiety and problems 
with the regulation of various neurotransmitters. The 
large numbers of neurotransmitters, peptides, hormones, 
and other neuromodulators have been implicated in fear 
and anxiety[3]. 5-HT pathway originating from the dorsal 
raphe nucleus (DRN) and innervating the amygdala and 
frontal cortex facilitates conditioned fear. Selective 5-HT 
reuptake inhibitors (SSRIs) and 5-HT1A or 5-HT3 receptor-
selective drugs can have anti-anxiety effects in certain 
anxiety disorders and animal models[4]. Several preclinical 
studies have shown that stress and anxiety cause a marked 
increase in NA release in several rat brain regions, 
including the hypothalamus, the amygdala, and the LC. 
毭-Aminobutyric acid (GABA) is the most abundant 
inhibitory neurotransmitter in the brain. The GABAA-
benzodiazepine receptor is an important target for several 
anxiolytic drugs and may therefore play an important 
role in anxiety-related disorders[5]. It is well reported 
that Diazepam, GABAA-benzodiazepine receptor agonist 
at the dose of 2 mg/kg, i.p. significantly showed anti-
anxiety activity in various behavioural paradigms of 
animals[6]. Several studies have shown that positive 
allosteric modulators (which potentiate GABA action), such 
as progesterone and allopregnanolone, have anxiolytic 
effects in various animal models[7]. Several peptides, 
such as cholecystokinin (CCK), neuro-peptide Y (NPY), 
tachykinins (substance P, neuro-kinins A and B), and 
natriuretic peptides (atrial natriuretic peptide or C-type 
natriuretic peptide) may play important roles in fear and 
anxiety-related behaviors[8]. There is increasing evidence 
that NO may underlie anxiety in the elevated plus-maze 
test, an animal model of anxiety. NO analogues have been 
found to reduce GABA-gated current via cGMP-dependent 
pathways, leading to anxiety[9]. cGMP downregulates GABA 
receptor function in hippocampus, an important area 
involved in anxiety[10]. The elevated plus-maze (EPM) test, 
one of the most popular animal models for research on 
anxiety, is based on the natural aversion of rodents for open 
spaces and uses an elevated plus-maze with two open and 
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two closed arms[11,12]. This test is rapid and was found to 
be sensitive to the effects of both anxiolytic and anxiogenic 
agents. The Light/Dark exploration test (LDT) is another 
commonly used model for anxiety[13], devised by Crawley[14], 
this test is based on the innate aversion of rodents to brightly 
illuminated areas and on the spontaneous exploratory 
behaviour of rodents in response to mild stressors, i.e. 
novel environment and light. The LDT has been widely 
adopted as an anxiolytic screening test in mice[15]. Thymol 
(2-isopropyl-5-methylphenol) is naturally occurring 
phenolic monoterpene derivative of cymene, which is 
found in the oils of thyme and plants such as Thymus 
vulgaris[16], Thymus glandulosus[17], Thymus hyemalis[18], 
Thymus zygis[19]. It exhibits multiple biological activities: 
antibacterial[20], antifungal[21], anti-oxidant[22], free radical 
scavenging[23] and anti-lipid peroxidative[24] properties. 
Thymol was also shown to have strong anti-inflammatory 
action by decreasing the release of inflammaroty metabolites 
like prostanoids, interleukins and leukotrienes[25,26]. Thymol 
acts as a GABAA receptor agonist/modulator[27]. 
2. Materials and methods
2.1. Animals
  Swiss albino mice of either sex (20-30 g) were employed 
in the present study. Animals were procured from Disease 
Free Small Animal House, LLRUVAS, Hisar, Haryana, 
India. Animals were provided normal diet and water ad 
libitum and were exposed to natural light and dark cycle at 
controlled room temperature of 20-25 曟. The animals were 
acclimatized to the laboratory condition before experiments. 
The animals were kept fasted 2 h before drug administration, 
all the behavioral paradigm ware performed during day 
time between 9 a.m. and 2 p.m.[28]. Experimental protocol 
was approved by Institutional Animal Ethics Committee 
(IAEC). Care of the animals was taken as per guidelines of 
the Committee for the Purpose of Control and Supervision of 
Experiments on Animals (CPCSEA), Ministry of Environment 
and Forests, Government of India.
2.2. Drugs and chemicals
  Thymol, Diazepam, Ethanol and Sodium chloride were 
used in this study. Thymol, was procured from Central Drug 
House (CDH) Ltd. India. Diazepam (Calmpose®); Ranbaxy 
Laboratories, Ltd., Gurgaon, India. Normal saline (0.9% NaCl) 
was used as vehicle for Diazepam while absolute ethanol 
solution (0.01%) was used as vehicle for Thymol. Volume of 
injection for mouse was 10 mL/kg.
2.3. Selection of doses
  Doses were selected on the basis of literature, i.e., Thymol 
(5, 10, 20 mg/kg, i.p.), Diazepam (2 mg/kg, i.p.)[29]. 
2.4. Behavioral paradigms
2.4.1. Elevated plus maze
  The elevated plus maze (EPM) was first proposed as 
an animal model of anxiety by Handley and Mithani[30]. 
Elevated plus maze consisted of two close arms, 16 cm伊5 
cm伊12 cm, and two open arm, 16 cm伊5 cm, connected to a 
central platform (5 cm伊5 cm). The maze was elevated to a 
height of 25 cm above the floor. During the experiment each 
mouse was placed in the central compartment face towards 
either of open arm, observed for 5 min to record the time 
spent in open arms, the total observation of experiment was 
5 min (300 s). An entry was counted when all four paws of 
the mouse entered an open or closed arm. Arm entry was 
defined as all four paws having crossed the dividing line 
between and arm and the central area[28]. Maze was washed 
thoroughly with 5% ethanol after each observation to remove 
odor[31]. Percent of time spent by mice in open arms was 
calculated as follows:
% =
Number of seconds spent in open arms 
300 total sec (5 min observation time)
伊100
2.4.2. Light/ dark test
  The light/dark test (LDT) model was first described by 
the Crawely and Goodwin[32]. The apparatus consisted of 
rectangular shaped box (45 cm伊27 cm伊27 cm) partition into 
two compartments connected by a 7.5 cm伊7.5 cm opening in 
the wall between the compartments. An animal was placed 
in the centre of the light compartment face toward opening 
of the wall and observed for 5 min, for time spent in open 
(white/light) compartment. Apparatus was thoroughly washed 
with 5% ethanol after each observation to remove odor[31]. 
Percent of time spent by mice in light area was calculated as 
follows:
% =
Number of seconds spent in light compartment 
300 total sec (5 min observation time) 
伊100
2.5. Experimental protocol
  There were six group of mice used in this study. Each 
group consisted of five mice. Behavior testing was performed 
carefully in stepwise manner i.e. mice in each group were 
subjected to maximum two behavioral tests of anxiety, one 
followed by another to minimize the stress, that may arise 
from continuous exposure to these paradigms. Doses and 
routes of administration of drugs were selected according to 
previous studies as reported in the literature. All treatments 
(vehicle, 10 mL/kg; Thymol 5, 10 and 20 mg/kg; Daizepam
2 mg/kg) were administered intraperitoneally (i.p.) in a fixed 
volume of 1 mL/100 g body weight in separate groups of 
mice. Behavior testing was performed i.e. drug was given to 
138 Sanjay Singh Bhandari et al./ Journal of Acute Disease (2014)136-140
each animal, after 30 min behavior testing was performed in 
EPM and LDT. 
2.6. Statistical analysis
  All the results were expressed as mean依SEM. All statistical 
analysis was done using one way analysis of variance 
(ANOVA) followed by the Tukey’s post hoc test. P<0.05 was 
considered as significant when compared to their respective 
control group.
3. Results
  In elevated plus maze and light/dark test, significant 
increase in percentage of time spent in open arms and 
significant increase in percentage of time spent in light 
compartment indicate anxiolytic-like effect respectively. On 
the other hand, significant decreased in above parameters 
indicates anxiogenic effect.
3.1. Effect of different drug treatments on mice behavior in 
elevated plus maze
  Diazepam significantly increased percentage of time 
spent in open arms of elevated plus maze. Thymol 20 mg/kg
significantly increased percentage of time spent in open 
arms as compared to vehicle (0.01% ethanol) treated mice. 
Therefore thymol (20 mg/kg) produced significant anti-
anxiety effect as compared to vehicle (0.01% ethanol) treated 
mice (Table 1; Figure 1).
Figure 1. Values are expressed as Mean 依 SEM, n=5 in each group. 
Data was analyzed by one-way ANOVA followed by Tukey’s Post- 
hoc test. aP<0.05  significant difference from vehicle 1 treated group, 
bP<0.001 significant difference from vehicle 2 treated group.
3.2. Effect of different drug treatments on mice behavior in 
light/dark test
  Diazepam significantly increased percentage of time spent 
in light compartment of light/dark test. Thymol (20 mg/kg) 
significantly increased percentage of time spent in light 
compartment of light/dark test as compared to vehicle (0.01% 
ethanol) treated mice. Therefore thymol (20 mg/kg) produced 
significant anti-anxiety effect as compared to vehicle (0.01% 
ethanol) treated mice (Table 2; Figure 2).
Table 1
Effect of different treatments on percentage of time spent by mice in 
open arms of elevated plus maze.
Treatments Dose (mg/kg, i.p.)
% of time spent in
open arms
Vehicle 1 (0.01% ethanol)        10 mL   12.46依0.75
Vehicle 2 (0.9% NaCl)        10 mL   13.01依2.07
Diazepam   2     33.80依2.29b
Thymol   5   12.13依2.56
Thymol  10   13.46依3.01
Thymol 20    17.13依2.50a
Values are expressed as Mean 依 SEM, n=5 in each group. Data 
was analyzed by one-way ANOVA followed by Tukey’s Post-hoc 
test. aP<0.05 significant difference from vehicle 1 treated group, 
bP<0.001 significant difference from vehicle 2 treated group.
Table 2
Effect of different treatments on percentage of time spent by mice in 
light compartment of light/dark test.
Treatments Dose (mg/kg, i.p.)
% of time spent  in
light compartment
Vehicle 1 (0.01% ethanol)        10 mL 15.73依2.65
Vehicle 2 (0.9% NaCl)        10 mL 16.46依2.82
Diazepam   2   37.93依2.41b
Thymol   5 16.86依2.87
Thymol  10 16.86依2.50
Thymol 20   21.00依2.30a
Values are expressed as Mean 依 SEM, n=5 in each group. Data was 
analyzed by one-way ANOVA followed by Tukey’s Post-hoc test. 
aP<0.05 significant difference from vehicle 1 treated group, bP<0.001 
significant difference from its vehicle 2 treated group.
Figure 2. Values are expressed as Mean 依 SEM, n=5 in each group. 
Data was analyzed by one-way ANOVA followed by Tukey’s Post- 
hoc test. aP<0.05 significant difference from vehicle 1 treated group, 
bP<0.001 significant difference from its vehicle 2 treated group.
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4. Conclusion
  Elevated plus maze (EPM) and Light/dark test box (LDT) 
are two best models of anxiety. These both come under 
ethologically based animal models of fear and anxiety and 
involves the animal’s spontaneous or natural reactions 
(e.g. flight, avoidance and freezing) to stress stimuli that do 
not explicitly involve pain or discomfort[33]. In the present 
study, only thymol 20 mg/kg dose produced significant 
anti-anxiety like activity among its three doses. Diazepam 
binds to a specific subunit on the GABAA receptor at a site 
distinct from the binding site of the endogenous GABA 
molecule, known as an allosteric site. The GABAA receptor 
is an inhibitory channel which, when activated, decreases 
neuronal activity. Benzodiazepines cause an increased 
opening of the chloride ion channel when GABA binds to its 
site on the GABAA receptor, leading to more chloride ions 
entering the neuron, which in turn leads to enhanced central 
nervous system depressant effects[34]. Thymol is a positive 
allosteric modulator of the GABAA receptor[35]. The GABA-
modulating and GABA-mimetic activities of thymol on 
human GABAA and fruitfly (Drosophila melanogaster Meig.) 
homomeric RDLac GABAA receptors expressed in Xenopu 
oocytes. Thymol enhanced the GABA-dependent chloride 
currents in oocytes expressing various human GABAA 
receptor isoforms as well as the insect GABAA receptor[36]. 
It has been observed that NO donors produce 5-HT release 
in a biphasic way, with low concentrations of NO donors 
decreasing 5-HT release in the hypothalamus and high 
concentrations increasing it. Both effects are mediated by 
cGMP[37]. There is evidence suggesting the role of NO/cGMP 
signaling pathway in effect of NO on anxiety[38]. Inhibition of 
NO/cGMP signaling pathway by inhibiting of NOS has been 
reported to produce anti-anxiety effect[39]. Thymus vulgaris 
oil showed a significant decrease in aflatoxin-induced 
increased production of NO in liver and kidney proved its 
NO modulating anti-oxidant activity[40]. Thymus vulgaris 
extract significantly inhibit the enhanced production of NO, 
induced by LPS and INF-毭 in a dose dependent manner[41].
Final conclusion of this study is that, the anti-anxiety like 
activity of thymol may through possible modulation of GABA 
pathway or/and NO-cGMP pathway or/and 5-HT pathway. 
Further study is needed to explore the precise mechanism in 
anxiety by the Thymol.
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